PD-CD133/BSH was characterized by its effective uptake by CD133+ GSCs, and the combination of PD-CD133/BSH and BSH extended survival in a nude mouse model of orthotopic glioma after neutron radiation. This evidence concerns the gene PROM1 and central nervous system cancer.